Lai YH - Search Results

1

Proscillaridin A inhibits lung cancer cell growth and motility through downregulation of the EGFR-Src-associated pathway.

Tsai JY, Weng CW, Lai YH, Tsai MF, Chen HY, Chen JJ. Tsai JY, et al. Among authors: lai yh. Am J Cancer Res. 2023 Nov 15;13(11):5352-5367. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058797 Free PMC article.

2

Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth.

Weng CW, Wei CH, Tsai JY, Lai YH, Chang GC, Chen JJW. Weng CW, et al. Among authors: lai yh. Int J Mol Sci. 2022 Mar 23;23(7):3487. doi: 10.3390/ijms23073487. Int J Mol Sci. 2022. PMID: 35408854 Free PMC article.

3

Peruvoside is a novel Src inhibitor that suppresses NSCLC cell growth and motility by downregulating multiple Src-EGFR-related pathways.

Lai Y, Chang H, Chen H, Chang G, Chen JJ. Lai Y, et al. Am J Cancer Res. 2022 Jun 15;12(6):2576-2593. eCollection 2022. Am J Cancer Res. 2022. PMID: 35812056 Free PMC article.

4

The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.

Lai YH, Yu SL, Chen HY, Wang CC, Chen HW, Chen JJ. Lai YH, et al. Carcinogenesis. 2013 May;34(5):1069-80. doi: 10.1093/carcin/bgt005. Epub 2013 Jan 9. Carcinogenesis. 2013. PMID: 23306212

5

Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.

Lin SY, Chang HH, Lai YH, Lin CH, Chen MH, Chang GC, Tsai MF, Chen JJ. Lin SY, et al. Among authors: lai yh. PLoS One. 2015 May 8;10(5):e0123305. doi: 10.1371/journal.pone.0123305. eCollection 2015. PLoS One. 2015. PMID: 25955608 Free PMC article.

6

Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.

Lai YH, Chen MH, Lin SY, Lin SY, Wong YH, Yu SL, Chen HW, Yang CH, Chang GC, Chen JJ. Lai YH, et al. Oncotarget. 2015 Sep 22;6(28):26252-65. doi: 10.18632/oncotarget.4761. Oncotarget. 2015. PMID: 26312766 Free PMC article.

7

AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways.

Lai YH, Lin SY, Wu YS, Chen HW, Chen JJW. Lai YH, et al. J Hematol Oncol. 2017 Nov 13;10(1):172. doi: 10.1186/s13045-017-0539-3. J Hematol Oncol. 2017. PMID: 29132432 Free PMC article.

8

Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.

Lee PJ, Ho CC, Ho H, Chen WJ, Lin CH, Lai YH, Juan YC, Chu WC, Lee JH, Su SF, Chen HY, Chen JJW, Chang GC, Li KC, Yang PC, Chen HW. Lee PJ, et al. Among authors: lai yh. Theranostics. 2021 Sep 21;11(19):9667-9686. doi: 10.7150/thno.62676. eCollection 2021. Theranostics. 2021. PMID: 34646392 Free PMC article.

9

Spermine attenuates the action of the DNA intercalator, actinomycin D, on DNA binding and the inhibition of transcription and DNA replication.

Wang SY, Lee AY, Lai YH, Chen JJ, Wu WL, Yuann JM, Su WL, Chuang SM, Hou MH. Wang SY, et al. Among authors: lai yh. PLoS One. 2012;7(11):e47101. doi: 10.1371/journal.pone.0047101. Epub 2012 Nov 8. PLoS One. 2012. PMID: 23144800 Free PMC article.

10

Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.

Wang CC, Lin SY, Lai YH, Liu YJ, Hsu YL, Chen JJ. Wang CC, et al. Among authors: lai yh. PLoS One. 2012;7(4):e33772. doi: 10.1371/journal.pone.0033772. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22529897 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,022 results

Search Page

Filters